Abstract
Objective
To evaluate the efficacy of 2 different regimens for labor induction in patients with unfavorable cervix not responsive to a first dose of dinoprostone vaginal insert.
Methods
Between November, 2011 and June, 2014, 338 patients underwent induction of labor. After standard 24 hours treatment, 94 singleton term pregnancies remained with a Bishop score ≤6 and were randomized into 2 different regimens: repeated vaginal dinoprostone (group A, n = 47) or intravenous oxytocin (group B, n = 47). Primary outcome was vaginal delivery, and the secondary outcomes were interval between labor induction and delivery and operative delivery rates.
Results
Vaginal deliveries were significantly higher (group A: 26/47 (55.3%) and group B 16/47 (34.0%), P < .05), and cesarean sections were significantly lower (group A 21/47 (44.7%) and group B 31/47 (66%), P < .05) in patients who received a double dose of dinoprostone. The intervals between labor induction and onset of labor and between labor induction and delivery were lower in the group treated with oxytocin. Neonatal outcomes were similar in the 2 groups.
Conclusion
A second dinoprostone vaginal insert is an effective and safe choice for patients with unfavorable cervix not responsive to a first 24 hours administration of dinoprostone for cervical ripening, and its use is associated with lower cesarean section rates.
Similar content being viewed by others
References
Timmons B, Akins M, Mahendroo M. Cervical remodeling during pregnancy and parturition. Trends Endocrinol Metab. 2010;21(6): 353–361.
Arulkumaran S, Gibb DM, Tamby Raja RL, Heng SH, Ratnam SS. Failed induction of labour. Aust N Z J Obstet Gynaecol. 1985;25(3):190–193.
Xenakis EM, Piper JM, Conway DL, Langer O. Induction of labor in the nineties: conquering the unfavorable cervix. Obstet Gynecol. 1997;90(2):235–239.
Thomas J, Fairclough A, Kavanagh J, Kelly AJ. Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database Syst Rev. 2014:6:CD003101.
ACOG Committee on Practice Bulletins - Obstetrics. ACOG Practice Bulletin No. 107: induction of labor. Obstet Gynecol. 2009;114(2 pt 1):386–397.
Macones GA, Hankins GD, Spong CY, Hauth J, Moore T. The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring: update on definitions, interpretation and research guidelines. Obstet Gynecol. 2008;112(3):661–666.
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 116: management of intrapartum fetal heart rate tracings. Obstet Gynecol. 2010;116(5):1232–1240.
Pevzner L, Rayburn WF, Rumney P, Wing DA. Factors predicting successful labor induction with dinoprostone and misoprostol vaginal inserts. Obstet Gynecol. 2009;114(2 pt 1):261–267.
Vrouenraets FP, Roumen FJ, Dehing CJ, van den Akker ES, Aarts MJ, Scheve EJ. Bishop score and risk of cesarean delivery after induction of labor in nulliparous women. Obstet Gynecol. 2005; 105(4):690–697.
Bishop EH. Pelvic scoring for elective induction. Obstet Gynecol. 1964;24:266–268.
Keirse MJ. Natural prostaglandins for induction of labor and pre-induction cervical ripening. Clin Obstet Gynecol. 2006;49(3): 609–626.
Triglia MT, Palamara F, Lojacono A, Prefumo F, Frusca T. A randomized controlled trial of 24-hour vaginal dinoprostone pessary compared to gel for induction of labor in term pregnancies with a Bishop score < or = 4. Acta Obstet Gynecol Scand. 2010;89(5): 651–657.
Wing DA, Ortiz-Omphroy G, Paul RH. A comparison of intermittent vaginal administration of misoprostol with continuous dinoprostone for cervical ripening and labor induction. Am J Obstet Gynecol. 1997;177(3):612–618.
Sanchez-Ramos L, Peterson DE, Delke I, Gaudier FL, Kaunitz AM. Labor induction with prostaglandin E1 misoprostol compared with dinoprostone vaginal insert: a randomized trial. Obstet Gynecol. 1998;91(3):401–405.
Bolnick JM, Velazquez MD, Gonzalez JL, Rappaport VJ, McIlwain-Dunivan G, Rayburn WF. Randomized trial between two active labor management protocols in the presence of an unfavorable cervix. Am J Obstet Gynecol. 2004;190(1): 124–128.
Garry D, Figueroa R, Kalish RB, Catalano CJ, Maulik D. Randomized controlled trial of vaginal misoprostol versus dinoprostone vaginal insert for labor induction. J Matern Fetal Neonatal Med. 2003;13(4):254–259.
Rozenberg P, Chevret S, Senat MV, Bretelle F, Paule Bonnal A, Ville Y. A randomized trial that compared intravaginal misoprostol and dinoprostone vaginal insert in pregnancies at high risk of fetal distress. Am J Obstet Gynecol. 2004;191(1): 247–253.
Tanir HM, Sener T, Yildiz C, Kaya M, Kurt I. A prospective randomized trial of labor induction with vaginal controlled-release dinoprostone inserts with or without oxytocin and misoprostol + oxytocin. Clin Exp Obstet Gynecol. 2008;35(1):65–68.
Ozkan S, Caliskan E, Doger E, Yucesoy I, Ozeren S, Vural B. Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial. Arch Gynecol Obstet. 2009;280(1):19–24.
Ramsey PS, Harris DY, Ogburn PL, Heise RH, Magtibay PM, Ramin KD. Comparative efficacy and cost of the prostaglandin analogs dinoprostone and misoprostol as labor preinduction agents. Am J Obstet Gynecol. 2003;188(2):560–565.
Bebbington M, Schmuel E, Pevzner L, et al. Misoprostol versus dinoprostone for labor induction at term: a randomized controlled trial. Am J Obstet Gynecol. 2003;189(6 suppl):s211.
Zanconato G, Bergamini V, Mantovani E, Carlin R, Bortolami O, Franchi M. Induction of labor and pain: a randomized trial between two vaginal preparations of dinoprostone in nulliparous women with an unfavorable cervix. J Matern Fetal Neonatal Med. 2011;24(5):728–731.
Marconi AM, Bozzetti P, Morabito A, Pardi G. Comparing two dinoprostone agents for cervical ripening and induction of labor: a randomized trial. Eur J Obstet Gynecol Reprod Biol. 2008; 138(2):135–140.
Facchinetti F, Fontanesi F, Del Giovane C. Pre-induction of labour: comparing dinoprostone vaginal insert to repeated prostaglandin administration: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2012;25(10):1965–1969.
Petrovic Barbitch M, Gnisci A, Marcelli M, et al. Cervical ripening at term with repeated administration of dinoprostone vaginal pessary. Gynecol Obstet Fertil. 2013;41(6):346–350.
Sanchez-Ramos L, Kaunitz AM, Delke I, Gaudier FL. Cervical ripening and labor induction with a controlled-release dinoprostone vaginal insert: a meta-analysis. Obstet Gynecol. 1999;94(5 pt 2):878–883.
Smith JG, Merrill DC. Oxytocin for induction of labor. Clin Obstet Gynecol. 2006;49(3):594–608.
Tan PC, Daud SA, Omar SZ. Concurrent dinoprostone and oxytocin for labor induction in term premature rupture of membranes: a randomized controlled trial. Obstet Gynecol. 2009;113(5): 1059–1065.
Khan RA, Khan ZE, Ashraf O. Concurrent versus sequential methods for labor induction at term. Int J Gynaecol Obstet. 2007;96(2):94–97.
Christensen FC, Tehranifar M, Gonzalez JL, Qualls CR, Rappaport VJ, Rayburn WF. Randomized trial of concurrent oxytocin with a sustained-release dinoprostone vaginal insert for labor induction at term. Am J Obstet Gynecol. 2002;186(1):61–65.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Antonazzo, P., Laoreti, A., Personeni, C. et al. Vaginal Dinoprostone Versus Intravenous Oxytocin for Labor Induction in Patients Not Responsive to a First Dose of Dinoprostone: A Randomized Prospective Study. Reprod. Sci. 23, 779–784 (2016). https://doi.org/10.1177/1933719115618272
Published:
Issue Date:
DOI: https://doi.org/10.1177/1933719115618272